NCT00113893 2013-11-07SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.Scios, Inc.Phase 2 Completed62 enrolled
NCT00095680 2010-10-22Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaScios, Inc.Phase 2 Completed30 enrolled
NCT00087867 2010-10-18Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaScios, Inc.Phase 2 Completed62 enrolled